APOE and metabolic dysfunction-associated steatotic liver disease: Statistically significant associations with NAFLD risk were found (but varied by populations) in 11 SNPs, including the rs738409 (PNPLA3), rs58542926 (TM6SF2), rs1260326 (GCKR), rs13118664 (HSD17B13), rs4808199 (GATAD2A), rs2954021 (TRIB2), rs4240624 (PPP1R3B), rs10883437 (CPN1), rs10883451 (ERLIN1), rs429358 (apolipoprotein E (APOE)), and rs641738 (MBOAT7)).